Zimbabwe has turned down a significant US healthcare agreement valued at $367m (£272m) spanning five years because of the United States' request for confidential information.
This move came to light following a official document from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesman later explained that the United States was demanding access to health data for scientific study and profit but refused to share the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further talks to secure a agreement agreeable to both sides so the nation's critical HIV treatment initiative can continue.
Broader Implications
This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and accountability.
According to statements, Sixteen African countries have so far signed these new health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, with no corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens should a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks previously established through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We welcome ongoing dialogue with our American counterparts on how future co-operation might be designed in a manner that respects the independence and interests of both nations."
Health Experts Reaction
Medical experts said it acknowledged the official position, but suggested that talks must proceed given that much of the country's Aids initiatives depended on international support.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it added.
This impasse highlights the continuing debate between accepting much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.